Andrew Greenstein

1 Patent

• US124404872025

  Method of Normalizing the Neutrophil to Lymphocyte Ratio in Cancer Patients with a Selective Glucocorticoid Receptor Antagonist

  Corcept Therapeutics Incorporated

  0 cites